T ranscriptional disturbance is implicated in the pathology of polyglutamine diseases, including Huntington's disease (HD). However, it is unknown whether transcriptional repression leads to neuronal death or what forms that death might take. We found transcriptional repression-induced atypical death (TRIAD) of neurons to be distinct from apoptosis, necrosis, or autophagy. The progression of TRIAD was extremely slow in comparison with other types of cell death. Gene expression profi ling revealed the reduction of full-length yes-associated protein (YAP), a p73 cofactor to promote apoptosis, as specifi c to TRIAD. Furthermore, novel neuron-specifi c YAP isoforms (YAP∆Cs) were sustained during TRIAD to suppress neuronal death in a dominant-negative fashion. YAP∆Cs and activated p73 were colocalized in the striatal neurons of HD patients and mutant huntingtin (htt) transgenic mice. YAP∆Cs also markedly attenuated Htt-induced neuronal death in primary neuron and Drosophila melanogaster models. Collectively, transcriptional repression induces a novel prototype of neuronal death associated with the changes of YAP isoforms and p73, which might be relevant to the HD pathology.
Introduction
Neurodegenerative disorders are characterized by the slow exacerbation of symptoms and by gradual progression of brain pathologies. Patients suffer for 5-20 yr from the onset of the disease to the bed-ridden state. Even fast-progressing amyotrophic lateral sclerosis takes 2-5 yr to render the patient bed ridden. Regarding the pathology, the total number of neurons and neural networks among them decrease. However, some of the neurons survive for an extensive period of time despite their expression of abnormal structures that are derived principally from the pathogenic disease-causing products. Typically, nigral neurons that express Lewy bodies in Parkinson's disease, hippocampal neurons that carry paired helical fi laments in Alzheimer's disease, and motor neurons bearing Bunina bodies in amyotrophic lateral sclerosis can partially survive until the death of the patient. The mutant protein aggregates that characterize many of these diseases are known to trigger multiple cellular responses, including ER stress and mitochondrial abnormality. These stress responses are clearly suffi cient to induce apoptosis in nonneuronal cell lines, whereas the brain pathology of patients indicates that neurons survive for a long period before their demise. A lengthy period of cell death is also observed in the polyglutamine (polyQ) diseases, a major group of neurodegeneration that includes nine disorders (for reviews see Gusella and MacDonald, 2000; Zoghbi and Orr, 2000; Ross, 2002; Taylor et al., 2002; Bates, 2003) . Again, a fraction of the neurons that possess nuclear and/or cytoplasmic inclusions of mutant polyQ peptides survives even in affected regions of the brain until the time of necropsy. So far, there is no model that fully explains the lengthy period of cell death in neurodegeneration.
In addition to ER and mitochondrial stresses, transcriptional dysfunction is suggested as a critical pathological component of polyQ diseases (for reviews see Gusella and MacDonald, 2000; Zoghbi and Orr, 2000; Ross, 2002; Taylor et al., 2002; Bates, 2003) . Translocation of mutant proteins to the nucleus seems essential for neuronal dysfunction or cell death in polyQ diseases (Klement et al., 1998; Saudou et al., 1998; Katsuno et al., 2003) . Numerous transcription-related factors, including LANP, PQBP-1, N-CoR, ARA24, p53, mSin3A, ETO/MTG8, was remarkably reduced at 6 h after the addition of 25 μg/ml AMA, indicating that AMA reduces transcription. (B) BrdU uptakes per neuronal nucleus at different concentrations of AMA (10 and 250 μg/ml) were analyzed chronologically. Signal intensities (AU, arbitrary unit) calculated with A Q U A C O S M O S (Hamamatsu) were obtained from >500 cells. Means ± SD are shown (error bars). Asterisks indicate signifi cant reductions compared with 0 h (P < 0.01, t test). (C) Survival curves of HeLa cells and primary neurons (cortical, cerebellar, and striatal [STR] neurons) with AMA (10, 25, and 250 μg/ml). Viability (percent) indicates live cells/total cells by trypan blue assay in six independent wells. Viability was shown as means ± SD of nonstained cells. Viability of HeLa cells declined at 24 h. In primary neurons, a signifi cant reduction was fi rst observed at 72 h at all concentrations of AMA. Of the three types of neuron tested, striatal neurons were the most vulnerable to AMA treatment for 48 h at 25 and 250 μg/ml AMA. P < 0.05 (t test).
P160/GRIP1, A2BP1, TAF II 130, CA150, CRX, Sp1, CtBP, PML, TAF II 30, NF-κB, and SC35, are known to interact or colocalize with mutant polyQ disease proteins (for reviews see Okazawa, 2003; Sugars and Rubinsztein, 2003) . Interaction with polyQ proteins may impair physiological functions of these transcription factors (Okazawa, 2003; Sugars and Rubinsztein, 2003) , and, fi nally, even the general transcription level could be repressed . Some of these polyQ pathologymediating factors bind directly to the core of transcription machinery, RNA polymerase II (Pol II; Okazawa et al. 2002) . Therefore, one of the paramount issues in the fi eld of polyQ diseases is the relationship between transcriptional dysfunction and neuronal death. However, as yet, the role of transcriptional disruption in neuronal death is unclear, as is the mode of neuronal death when transcription is severely impaired.
In this study, we found that inhibition of Pol II-dependent transcription leads neurons to undergo a slowly progressive atypical cell death (transcriptional repression-induced atypical death [TRIAD] ) distinct from apoptosis, necrosis, or autophagy in morphological and biochemical analyses. Transcriptome analysis of TRIAD suggested that yes-associated protein (YAP), a known transcriptional cofactor, might be relevant to the death process. YAP, which was originally found as a binding protein to Src homology domain 3 of the yes proto-oncogene product (for review see Sudol et al., 1995) , acts as a transcriptional cofactor of p73, mediates the expression of cell death-promoting genes, and induces apoptosis (Yagi et al., 1999; Basu et al., 2003; Melino et al., 2004) . We found that in TRIAD, full-length YAP (FL-YAP) is down-regulated, and novel neuron-specifi c YAP∆C isoforms lacking the cell death-promoting activity sustain to protect neurons in a dominant-negative manner. The shift of balance in YAP isoforms seemed to slow down the cell death signaling pathway of p73 activated by α-amanitin (AMA), at least partially. We further questioned the relevance of YAP and p73 to Huntington's disease (HD) by using cellular, Drosophila melanogaster, and mouse models as well as human brain samples. Our data suggest that these molecules might be involved in neuronal death triggered by mutant Htt, the causative gene product of HD.
Results

Transcriptional repression induces an atypical slow neuronal death
To address the role of transcriptional disruption in neuronal death, we fi rst made multiple short inhibitory RNAs (siRNAs) against RNA Pol II to suppress Pol II-dependent transcription. However, suppression of Pol II was inadequate and reminiscent of recent efforts to suppress basic transcription machinery by similar approaches (Ni et al., 2004) . Therefore, we used a specifi c inhibitor of Pol II (AMA) whose three-dimensional molecular structure is exactly complementary to the groove of Pol II, through which mRNA is elongated (Cramer et al., 2001; Bushnell et al. 2002) . Different concentrations of AMA were added to the culture medium of HeLa cells, primary rat embryonic (embryonic day [E] 15) cortical neurons, rat E15 striatal neurons, and rat pup cerebellar neurons (postnatal day [P] 7). BrdU up-take assay showed signifi cant repression of transcription at 6 h of AMA treatment in primary neurons (Fig. 1, A and B ) and HeLa cells (not depicted). The survival of AMA-treated cells estimated by trypan blue assay (Fig. 1 C) revealed that AMA induces a slowly progressive cell death in a dose-dependent fashion. This was most pronounced in primary neurons, with half-lives of nearly 5 d. AMA-induced neuronal death was much slower than low potassium-induced apoptosis of cerebellar neurons, whose half-life was ‫21ف‬ h (not depicted). The slow progression of AMA-induced neuronal death was confi rmed independently by MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide) assay (Fig. S1 , available at http://www.jcb.org/cgi/content/full/jcb.200509132/DC1).
A population of HeLa cells (10-30%) began to show cytoplasmic vacuoles proximal to the nucleus (Fig. 2 A, HeLa-TRIAD) from 6-12 h after the addition of AMA. Similar vacuoles were also observed in cortical neurons treated with AMA for 2 d (Fig. 2 A, CTX neuron-TRIAD), although with a diminished frequency (1-5%). It is important to note that the vacuoles did not possess double-membrane structures reminiscent of autophagosomes. No classic apoptotic features such as chromatin condensation, nuclear fragmentation, or apoptotic bodies (Okazawa et al., 1996) were found in these neurons by electron microscopic analysis (Fig. 2 A) . In addition, no necrotic features such as mitochondrial dilatation (Fig. 2 A, CTX neuron necrosis) or cytoplasmic ballooning and rupture ( Fig.  2 A, CTX neuron necrosis) were observed in primary neurons under TRIAD.
Immunohistochemical analyses using organelle-specifi c antibodies excluded the idea that the cytoplasmic vacuole was derived from the Golgi apparatus, endosome, lysosome, and mitochondria (Fig. S2 , available at http://www.jcb.org/cgi/ content/full/jcb.200509132/DC1). Autophagosomes induced by rapamycin and labeled with EGFP-LC3, a marker protein of the autophagosome (Fig. 2 B, top and middle), failed to colocalize with AMA-induced vacuoles (Fig. 2 B, bottom) . In addition, the size of AMA-induced vacuoles was larger than that of autophagosomes ( Fig. 2 B, bottom) . EGFP-LC3 actually expresses the LC3 peptide (Fig. 2 C, arrow) , verifying the morphological result. Note that the immunoblot shows a nonspecifi c band that is consistently detected by this antibody (Fig. 2 C, asterisk; unpublished data). Furthermore, the addition of rapamycin to the medium increased LC3-positive vacuoles but did not affect the formation of LC3-negative vacuoles induced by AMA (Fig. S3 A) . Collectively, these data suggested that AMA-induced cell death is distinct from autophagy. Finally, we found colocalization of the vacuoles with ECFP-ER fusion constructs (expressing calreticulin ER-targeting sequences and KDEL ER retrieval tags at the 5′ and 3′ ends, respectively, of ECFP; Fig. 2 D) . It suggested that vacuoles might be derived from expanded ER.
In agreement with the absence of morphological features of apoptosis, genomic DNA analyses of cell lines and primary neurons did not show ladder formation after AMA treatment (Fig. 3 A) . Caspase-3, -7, and -12 were not remarkably activated in primary neurons by AMA (Fig. 3 B) . AMA induced neither the release of cytochrome c into the cytosol from these neurons (Fig. 3 C) nor the interaction of annexin-V with the membrane of these neurons at an early stage (Fig. S3 B) . Caspase inhibitors z-DEVD-fmk and z-VAD-fmk did not repress AMA-induced cell death in neurons or in HeLa cells (not depicted). As expected, cycloheximide did not affect the cell death (not depicted). Calpain inhibitors, including ALLN and ALL, showed no remarkable effect on cell death. Pretreatment of cells with different concentrations of ATP in the medium did not affect AMA-induced cell death (not depicted).
Although AMA is a highly specifi c inhibitor of Pol II, as confi rmed by molecular structural analyses (Cramer et al., 2001; Bushnell et al. 2002) , to further verify that AMA-induced cell death is mediated by transcriptional repression, we examined the effect of another type of transcription inhibitor, actinomycin D, on primary neurons (Fig. S4 , available at http://www. jcb.org/cgi/content/full/jcb.200509132/DC1). Actinomycin D binds directly to DNA and inhibits transcription (Jones, 1976) by stalling the rapidly moving fraction of Pol II (Kimura et al., 2002) . We found that actinomycin D also induced a slowly progressive neuronal death (Fig. S4 A) , in which some neurons show cytoplasmic vacuoles similar to those by AMA (Fig.  S4 B) . Neither DNA fragmentation nor caspase activation was induced by actinomycin D (Fig. S4, C and D) . Collectively, our results suggest that AMA induces a slowly progressive TRIAD of neurons that is distinct from apoptosis, necrosis, and autophagy.
Novel YAP isoforms are expressed in neurons specifi cally
To understand the molecular basis of TRIAD, we conducted microarray analysis and compared gene expression profi les between TRIAD and low potassium-induced apoptosis in primary neurons. To detect initial changes, neurons were harvested at 1 h for RNA preparation. Duplicate experiments allowed us to extract eight genes whose expression levels changed in both apoptosis and TRIAD and a further 11 genes whose expression was changed specifi cally in TRIAD (Fig. 4 A) . The latter group included YAP (Fig. 4 B) , a transcriptional coactivator of p73 mediating apoptosis (Basu et al., 2003) . Detailed information of the selected genes is provided in Fig. S5 (available at http:// www.jcb.org/cgi/content/full/jcb.200509132/DC1). Northern blotting confi rmed that AMA treatment down-regulates YAP expression at the level of transcription (Fig. 4 C) .
Surprisingly, however, we identifi ed novel isoforms of YAP containing 13-, 25-, and 61-nt inserts (Fig. 4 , D and E) in addition to the full-length form by PCR cloning with RNA extracted from nontreated normal cortical and cerebellar neurons. The insert sequences matched genomic sequence with consensus junction sequences (Fig. 5 ). All three insertions lead to a reading frame shift, causing truncation of the COOH-terminal transcriptional activation domain (Fig. 4, D and E; Yagi et al., 1999) . Therefore, we designated them YAP∆Cs. Tissue expression profi ling by RT-PCR revealed that the 13-and 61-nt insert isoforms (denoted here as Ins13 and Ins61, respectively) relatively specifi c to neurons (Fig. 4 F) . Brain tissue (Fig. 4 F, third lane; not CTX or CBL neurons), including many glial and nonneuronal cells, showed only faint signals of the 13-nt variant comparable with those seen in other tissues (Fig. 4 F) . Ins61 was highly specifi c to cortical neurons (Fig. 4 F) . The 25-nt insert could not be detected by RT-PCR. Supporting the expression of YAP∆Cs in neurons, a truncated YAP isoform-specifi c antibody stained cortical and striatal neurons in immunohistochemistry with human and mouse brains (see Figs. 8 and 9) .
In addition, temporal regulation of YAP isoforms during TRIAD was observed by Western blot analysis. Interestingly, although FL-YAP decreased before day 3 in cortical neurons, YAP∆Cs were expressed at a relatively constant level (Fig. 4 G) . It is also important to note that the levels of YAP∆Cs were signifi cantly lower in HeLa cells (Fig. 4 G) . These data prompted us to test the function of YAP isoforms in TRIAD.
YAP isoforms modulate TRIAD
p73 and YAP mediate cisplatin (CDDP)-induced apoptosis of a cancer cell line, MCF-7 cells (Basu et al., 2003) . In this case, DNA damage induced by CDDP leads to activation of p73, and the transcription cofactor YAP promotes p73-mediated transactivation of cell death genes, including Bax and possibly PUMA . Truncation of the transcriptional activation domain (Yagi et al., 1999) in YAP may impede transduction of the cell death stimulus, and YAP∆Cs may act as dominant negatives against FL-YAP. As expected, luciferase assay showed that expression of YAP∆C isoforms represses p73-mediated activation of the p21/WAF1 gene promoter in MCF-7 cells by CDDP (Fig. 6 A, left; Basu et al., 2003) . Overexpression of FL-YAP did not promote transcriptional activation any more (Fig.  6 A) probably because the function of endogenous FL-YAP was saturated. YAP∆Cs also showed repressive effects on CDDPinduced apoptosis of MCF-7 cells (Fig. 6 B) mediated by FL-YAP (Basu et al., 2003) . In these assays, the expression of each truncate was confi rmed in parallel (Fig. 4, A and B; right) .
Next, we tested whether YAP∆Cs could repress TRIAD of primary cortical neurons (Fig. 6 C) . Before the addition of AMA, neurons were infected with adenovirus vectors for YAP∆Cs or the empty adenovector (AxCA) as a negative control (Fig. 6 C, left) . Expression of YAP∆Cs was confi rmed by Western blot analysis simultaneously (Fig. 6 C, right) . To further test whether YAP∆Cs are involved in TRIAD, we transfected a siRNA targeting a sequence shared by three YAP∆C isoforms but not FL-YAP (Fig. 6 D) . The siRNA accelerated TRIAD to ‫%09ف‬ (Fig. 6 D) , supporting the idea that YAP∆Cs suppress the cell death process in TRIAD at least partially.
The suppression of TRIAD by YAP∆Cs suggested, in turn, that p73, the target transcription factor of FL-YAP, would be activated in TRIAD. Therefore, we analyzed the amount and phosphorylation of p73 in AMA-treated cortical neurons at day 2. As expected, AMA accelerated the phosphorylation of p73, whereas the total amount of p73 was not changed (Fig.  6 E) . Together with the former results, YAP∆Cs might inhibit the action of p73, leading neurons to apoptosis by antagonizing FL-YAP, especially at the early phase of TRIAD when FL-YAP is still expressed (Fig. 4 G) .
Relevance of YAP isoforms and p73 to HD pathology
To investigate the relevance of YAP isoforms to the HD pathology, we infected primary cortical neurons with adenovirus vectors of YAP∆Cs and found that expression of the truncated isoforms repressed Htt111-induced cell death of cortical neurons at 4 d after the infection of adenovirus vectors (Fig. 7 A; Tagawa et al., 2004) . Consistently, YAP∆C-specifi c siRNA promoted Htt-induced cell death of cortical neurons (Fig. 7 B) . We also found that mutant Htt induced p73 phosphorylation in cortical neurons at 2 d after infection (Fig. 7 C) . Suppression of p73 by siRNA repressed cell death of mutant Htt-expressing neurons at day 4 (Fig. 7 D) , suggesting the relevance of p73 to Htt-induced neuronal death. To examine the possible involvement of p73 Figure 5 . Genomic structures of YAP C isoforms. Genomic sequence numbers are derived from rat chromosome 8 supercontig. cDNA nucleotide sequences of novel YAP isoforms are available from GenBank/ EMBL/DDBJ accession no. DQ186896, DQ186897, and DQ186898. Gray and black boxes are exons; black boxes indicate exons that were newly identifi ed in this study. Luciferase assays were performed with MCF-7 cells 24 h after transfection of a p21/WAF1 reporter plasmid containing the p73 consensus cis-element and a YAP∆C expression vector (left). 25 μM CDDP was added 2 h after transfection. CDDP increased the transcription level to about threefold. Expression of YAP∆C isoforms (ins13, ins25, and ins61) remarkably repressed transcriptional activation by CDDP. FL-YAP (YAP) did not enhance the transcriptional activation, suggesting that endogenous YAP function was saturated. The expression of YAPs was checked simultaneously (right). n = 6. (B) YAP∆Cs suppressed in vivo, we analyzed p73 activation with brain samples of human HD patients. Western blotting with human brain samples suggested higher levels of p73 phosphorylation in HD brains than in control brains (Fig. 7 E) .
Correspondingly, immunohistochemical analysis revealed an increase of phosphorylated p73 in striatal neurons of mutant Htt transgenic mice (R6/2) at 4 wk (Fig. 8, middle) . It is noteworthy that antiphosphorylated p73 antibody stained both the nucleus and cytoplasm of striatal neurons in R6/2 mice (Fig. 8,  middle) , although anti-p73 antibody detecting both nonphosphorylated and phosphorylated p73 proteins (full-length and NH 2 -terminus deletion forms) dominantly stained the cytoplasm (Fig. 8, left) . On the other hand, YAP∆Cs were expressed in striatal neurons of both normal and R6/2 transgenic mice, whereas the signal was relatively stronger in transgenic mice (Fig. 8, right) .
Furthermore, phosphorylation of p73 was detected in striatal neurons of human HD patients (Fig. 9 A) , suggesting that p73 is activated in human HD pathology. In this experiment (Fig. 9 B) , because we used the antibody detecting full-length p73 but not ∆Np73, the full-length form of p73 was considered to be phosphorylated (Fig. 9 B, top) . YAP∆Cs were shown to exist in striatal neurons of human HD patients by a specifi c antibody ( Fig. 9 A, bottom right) and to be colocalized with activated p73 in striatal neurons (Fig. 9 B, bottom) . It is important to note that phosphorylated p73 and YAP∆Cs were at very low levels in control human brains (Fig. 9 A, top) . Collectively, these results suggest the possibility that p73 and YAP∆Cs might be involved in the HD pathology.
YAP C isoforms attenuate Htt-induced neurodegeneration of Drosophila
Finally, we examined the in vivo effect of YAP∆Cs on Httinduced neurodegeneration in Drosophila models (Jackson et al., 1998) . We generated more than three transgenic fl y lines of human YAP∆Cs. In the transgenic fl ies, the expression of YAP∆C protein was triggered by GMR-GAL4 that directs expression in the developing and adult eyes. To analyze the effects on photoreceptor neuron degeneration and/or the characteristic eye phenotype induced by the expression of human Htt120Q, we compared eye phenotypes between the F1 sibling fl ies at 10 d directly under the microscopy or by toluidine blue staining of 2-μm sections of epon-embedded eye tissues. Ommatidia structure and photoreceptor neurons were severely disrupted in GMR-Htt120Q/GMR-GAL4 double-transgenic fl ies (BL8533; Jackson et al., 1998) , whereas the expression of YAP∆C with a 61-nt insert (YAP∆C61) markedly preserved structure in triple-transgenic fl ies (GMR-Htt120Q/GMR-GAL4/UAS-YAP∆C61; Fig. 10 A) . Expression levels of YAP∆C61 and Htt120Q were checked in the same fl y in parallel (Fig. 10 B) . Quantitative analysis of rhabdomere numbers per ommatidium in four independent transgenic fl y lines supported the repression of neurodegeneration by YAP∆C61 (Fig. 10 C) . We observed similar improvement of neurodegeneration in other YAP∆C transgenic Drosophila fl ies (not depicted). Collectively, these in vivo data further suggest the possibility that YAP∆C isoforms might play a protective role against the toxicity of mutant Htt in HD pathology.
Discussion
In this study, we report atypical neuronal death induced by transcriptional repression (TRIAD). Transcriptional repression by Pol II-specifi c inhibitors leads to a very slow atypical neuronal death whose progression is clearly different from the wellknown cell death prototypes. A morphological feature of TRIAD might be the vacuolization of ER, although it should be stressed that the majority of neurons (>90%) do not show remarkable morphological changes. These fi ndings might be relevant to the roles of transcriptional disturbance in HD disease (for review see Gusella and MacDonald, 2000; Zoghbi and Orr, 2000; Ross, 2002; Taylor et al., 2002; Bates, 2003; Okazawa, 2003; Sugars and Rubinsztein, 2003) . In addition, the lengthy progression of TRIAD might cast light on the basic question of why neurons stay alive under neurodegeneration for a long period.
To the best of our knowledge, there are a few atypical cell deaths that might be partially analogous to TRIAD. One is a lengthy cell death of Dictyostelium discoideum during sorocarp formation, in which dying cells show cytoplasmic vacuolization (Cornillon et al., 1994) . The second, termed paraptosis, is induced by the overexpression of the intracellular domain of insulinlike growth factor I (IGF-I) receptor in 293T cells (Sperandio, et al., 2000) . Paraptosis is characterized by vacuolization of the ER but no nuclear fragmentation, cellular blebbing, or apoptotic body formation (Sperandio, et al., 2000) . These two atypical cell deaths might share molecular pathways (Wyllie and Goldstein, 2001 ). Although TRIAD shows a related morphological change, TRIAD is clearly different from paraptosis, as the latter is inhibited by both actinomycin D and cycloheximide (Sperandio, et al., 2000) . Another point that distinguishes TRIAD from paraptosis is the cell death stimulus. Paraptosis was reported only in ectopic expression of truncated IGF-I receptor in CDDP-induced apoptosis of MCF-7 cells. 25 μM CDDP was added to the medium 24 h after infection of adenovirus vectors, and cell death assay was performed with annexin-V nonneuronal cells (Sperandio, et al., 2000) . Furthermore, the role that we fi nd for YAP in TRIAD has not been demonstrated in paraptosis or D. discoideum cell death. It is noteworthy that Degterev et al. (2005) has recently reported a new type of cell death-necroptosis. They showed that in the absence of intracellular apoptotic signaling, extrinsic TNF stimulation triggers nonapoptotic cell death, showing necrotic morphology and autophagy. Although rapamycin did not increase typical LC3-negative vacuoles of TRIAD (Fig. S3) negating the autophagic component in TRIAD, we need to analyze carefully the relationship between TRIAD and necroptosis, including the viewpoint of cell death speed.
It is also necessary to consider TRIAD with previous classifi cations of cell death. Schweichel and Merker (1973) classifi ed three types of cell death. Type 1 was manifested as nuclear condensation and pyknosis, reduced cytoplasmic volume, and late cell fragmentation/phagocytosis. Type 2 was an autophagic vacuolization in the cytoplasm, and type 3 was described as cytoplasmic cell death in which general organelle breakdown was apparent. Type 1 is apoptosis, and types 2 and 3 were necrotic (Schweichel and Merker, 1973) . In 1990, Peter Clarke redefi ned an earlier model of cell death developed by Schweichel and Merker (Clarke, 1990 ). Clarke's modifi cation was to expand the forms of cytoplasmic cell death into types 3A and 3B. 3A is a nonlysosomal breakdown, and 3B is cytoplasmic (Clarke, 1990) . Cells undergoing the 3A type of cell death show an initial swelling of cytoplasmic organelles and the generation of vacuoles that eventually fuse with the extracellular space. A breakup of cell structure without autophagic or heterophagic activity occurs. In type 3B death, which is also known as the cytoplasmic form of cell death, swollen organelles (dilated perinuclear space, ER, and Golgi apparatus) are apparent as well as vacuoles. The cell membrane retracts, and the nucleus becomes karyolytic/edematous. Heterophagic elimination can occur. Type 3B has also been termed paraptosis/oncosis. Among these, TRIAD is close to type 3B. However, in addition to the aforementioned reason, TRIAD seems to be different from type 3B because vacuolization of ER is far more remarkable than morphological changes of other organelles in TRIAD.
In HD models, several studies have reported atypical cell death with cytoplasmic vacuolization. Sapp et al. (1997) reported that mutant Htt accumulates in punctate structures mimicking endosomal-lysosomal organelles of affected HD neurons. They further showed by extensive analyses, including immunoelectron microscopy, that mutant Htt appears in autophagosomes (Kegel et al., 2000) . Other studies also pointed out the possible involvement of autophagy in the HD disease pathology (Nagata et al., 2004; Ravikumar et al., 2004; Iwata et al., 2005) . Meanwhile, Hirabayashi et al. (2001) isolated VCP (valosincontaining protein)/p97, a member of the AAA+ family of ATPase proteins, as a HD-interacting protein. The expression of the mutant form of VCP leads to cytoplasmic vacuolization, which might be homologous to vacuoles in TRIAD because they were fused to ER (Hirabayashi et al., 2001) . Collectively, although our results so far seem to negate the identity of the TRIAD vacuoles to autophagosomes, we cannot exclude the possibility that they might share certain characteristics with the vacuoles reported in HD models.
As for the molecular pathway of TRIAD, YAP∆Cs and p73 might modify the process. Up-or down-regulation of YAP∆Cs suppresses or enhances TRIAD in cortical neurons, respectively (Fig. 6, C and D) . Together with evidence that AMA treatment increases active p73 in neurons (Fig. 6 E) and that YAP∆Cs remain during TRIAD of cortical neurons (Fig.  4 G) , these data suggest that p73-mediated cell death signaling might be attenuated by YAP∆Cs in TRIAD. Consistently, the percentage of morphologically changed neurons (vacuolepossessing neurons) was very low. It might be a reason why TRIAD does not progress rapidly like apoptosis.
p73 was activated in human and mouse HD pathology in vivo (Figs. 8 and 9 ). YAP∆C isoforms were coexpressed in affected neurons of human HD patients (Fig. 9) . Repression of p73 and expression of YAP∆Cs attenuated Htt-induced neuronal cell death of primary neurons (Fig. 7, A and D) , whereas YAP∆C repression enhanced the neuronal cell death (Fig. 7 B) . Furthermore, YAP∆C isoforms suppressed neurodegeneration of photoreceptor cells of Drosophila in vivo (Fig. 10) . These fi ndings suggest that YAP∆Cs and p73 might be relevant to the HD pathology.
p53 has been implicated in the HD pathology because p53 coaggregates with mutant Htt (Steffan et al., 2000) . Bae et al. (2005) recently reported that mutant Htt interacts with, Figure 8 . YAP C and phosphorylated p73 are expressed in striatal neurons of Htt transgenic mice. Immunohistochemical analyses of mutant Htt transgenic (R6/2) and sibling control mice were performed at 4 wk with antip73 (full-length form), antiphosphorylated p73, or anti-YAP∆C antibodies. Arrows indicate immunoreactive striatal neurons. Expression of phosphorylated p73 was increased in R6/2 transgenic mice (middle), whereas the total amount of p73 was similar in transgenic and control mice (left). Immunoreactivities of YAP∆C were slightly increased in transgenic mice (right).
translocates, and activates p53. They also showed that mating mutant Htt transgenic mice with p53-null mice ameliorates neurological symptoms by mutant Htt (Bae et al., 2005) . These results suggest that p53 activation promotes the HD pathology. Because p73 and p53 belong to the same family of transcription factors recognizing a similar consensus sequence on genomic DNA (for review see Irwin and Miller, 2004) , the common cascade shared by the two factors should be investigated in the HD pathology. For instance, upstream signals activating these two factors and target gene activation by these transcription factors in the HD pathology should be analyzed in the future. On the other hand, because p53 is suggested to have a direct effect on mitochondria (Mihara et al., 2003) , it might be necessary to test whether p73 also plays a similar role.
It is important to note that hyperactive p73 could trigger vacuolar changes of ER in nonneuronal cells (Terrinoni et al., 2004) . If this is true, the vacuole formation in TRIAD might be triggered by activated p73. In this case, although ER stress could be induced by mutant polyQ protein (Kouroku et al., 2002; Nishitoh et al., 2002) , ER stress might also be evoked by a signal from the nucleus in parallel. Investigation on the possible connection between the nucleus and ER might contribute to understanding the polyQ pathology. The hypothetical pathway should be examined and elucidated in the future. In summary, our results present a novel model of cell death that might cast more light on the HD pathology.
Materials and methods
Primary neuron culture
Cerebral cortex tissues isolated from E17 Wistar rat embryos and cerebellar tissues isolated from P7 Wistar rat pups were minced (with razors) and treated with 0.25% trypsin (Invitrogen) in PBS, pH 7.5, at 37°C for 20 min with gentle shaking every 5 min. After stopping the reaction with DME containing 50% FBS, DNase I (Boehringer) was added to the solution at a fi nal concentration of 100 μg/ml, and tissues dissociated gently by pipetting with blue tips. Cells fi ltered by nylon mesh (pore size of 70 mm; Falcon; BD Biosciences) were collected by centrifugation, resuspended in DME supplemented with 20 mM glucose, 16 mM sodium bicarbonate, 4 mM glutamine, 25 μg/ml gentamicin, and 10% FBS, and plated on 24-well dishes (Corning) coated by poly-L-lysine (Sigma-Aldrich) at 3 × 10 5 cells/well. 12 h after plating, cytosine arabinoside was added to the culture medium at 4 M of fi nal concentration to prevent the growth of glial cells. Cerebellar neurons were cultured at high potassium (25 mM) ordinarily but were cultured at 5.4 mM potassium to induce apoptosis. Cortical neurons were cultured at low potassium condition (5.4 mM). Necrosis of cortical neurons Figure 9 . YAP C and phosphorylated p73 are coexpressed in striatal neurons of human HD brain. (A) Immunoreactivities of phosphorylated p73 and YAP∆C isoforms were increased in striatal neurons of HD patients (arrows). Postmortem brain tissues, including the caudate nucleus, were prepared from three HD patients and three controls. (B) Double staining with anti-p73 rabbit polyclonal antibody specifi c for full-length p73 but not reactive to ∆Np73 (H-79; 1:500; Santa Cruz Biotechnology, Inc.) and with antiphospho-p73 rabbit polyclonal antibody (1:500; Cell Signaling) showed colocalization of the two signals in most striatal neurons of HD patients (top, white arrows). It suggests that the full-length p73 is phosphorylated in striatal neurons. Bottom panels show that YAP∆C isoforms were colocalized with phosphorylated p73 in striatal neurons (bottom, white arrows). However, a minor portion of neurons expresses only p73 (red arrows).
was induced by the freeze and thaw treatment. To induce TRIAD, AMA (Sigma-Aldrich) was added to the medium at a fi nal concentration of 10 or 25 μg/ml, except for dose-response survival experiments in which the fi nal concentration was 10-250 μg/ml. Actinomycin D (Sigma-Aldrich) was added to the medium at 0.1, 0.5, or 2.5 μg/ml.
Cell death assay
Cell death assays were performed either by trypan blue dye exclusion assay or MTT assay as described in each fi gure legend. For trypan blue assay, cells were incubated for 5 min in 0.4% trypan blue (Invitrogen). Blue-stained (nonviable) and nonstained (viable) cells were counted (at least 2,000 cells for each condition) in 10-20 visual fi elds randomly selected at 100× from each of three dishes, as described previously . MTT assay was performed with MTT cell proliferation/viability assay (R&D Systems) according to the commercial protocol. At each time point, the value of drug-treated cells was corrected to the value of nontreated cells as 100%.
Acquisition and processing of microscopic images
Regarding electron microscopic observation, cells were washed with PBS three times, fi xed in 2.5% glutaraldehyde/0.1 M phosphate buffer, and treated with 1% OsO 4 /0.1 M phosphate buffer for 2 h. Fixed cells were dehydrated through a graded ethanol series and embedded in epoxy resin. Ultrathin sections were stained with uranyl acetate and lead citrate and examined with a transmission electron microscope (H-9000; Hitachi) at 24°C (5,000-50,000×). Numerical aperture of the objective lens was 4, and the imaging medium was air. Data acquisition was performed by electron microscope fi lm.
As for immunocytochemistry, stained cells were observed with a microscope (IX-71; Olympus) at RT (20 or 40×; NA 0.40 or 0.60, respectively), and the imaging medium was air. Data acquisition was performed with a camera (C4742-95-12ERG; Hamamatsu), a controller (ORCA-ER; Hamamatsu), and A Q U A C O S M O S software (Hamamatsu). The fl uorochromes will be described in each method.
Analysis of autophagy
24 h after transfection of pEGFP-LC3, HeLa cells were treated with 10 μg/ml AMA and observed by fl uorescence microscopy (Fig. 2) . To further analyze the relationship between LC3-positive phagosomes and AMA-induced vacuoles, autophagy was induced by 200 ng/μl rapamycin for 2 h (Sigma-Aldrich; for review see Klionsky and Emr, 2000) . LC3-positive and -negative vacuoles were counted in the presence or absence of AMA. HeLa cells were transfected with pEGFP-LC3 by SuperFect (QIAGEN), collected 36 h after transfection, and subjected to Western blot analysis. Anti-EGFP polyclonal antibody (BD Living Colors) and anti-LC3 antibody were used at dilutions of 1:1,000 and 1:2,000, respectively. pEGFP-LC3 and anti-LC3 antibody were gifts from T. Yoshimori (National Institute of Genetics, Mishima, Japan) and N. Mizushima (Tokyo Metropolitan Institute for Medical Science, Tokyo, Japan).
Identifi cation of AMA-induced vacuolization
After treatment of AMA (Sigma-Aldrich) for 6 h, HeLa cells were washed with PBS and fi xed using 4% PFA for 15 min at RT. Cells were incubated for 1 h at RT with the following primary antibodies: anti-CCO1 mouse monoclonal antibody (1:100; Invitrogen); anti-EEA1 mouse monoclonal antibody (1:100; Transduction Laboratories); anti-Golgi58k mouse monoclonal antibody (1:100; Sigma-Aldrich); and anti-CD63 (1:100; Cymbus Biotechnology Ltd.). Secondary antibodies conjugated with AlexaFluor488 (Invitrogen) were used at a dilution of 1:1,000 and hybridized for 30 min at RT. HeLa cells were transfected by pEGFP-LC3 (a gift of N. Mizushima and T. Yoshimori; Kabeya et al., 2000) or pECFP-ER (BD Biosciences) using Superfect (QIAGEN) according to the manufacturer's instructions.
Western blot analyses of caspase-3, -7, and -12
Primary neurons were treated with 25 μg/ml AMA as indicated and were dissolved in 62.5 mM Tris-HCl, pH 6.8, 2% (wt/vol) SDS, 2.5% (vol/vol) 2-mercaptoethanol, 5% (vol/vol) glycerin, and 0.0025% (wt/vol) bromophenol blue on culture dishes. Positive controls for caspase-3 and -7 were prepared from HeLa cells treated with 1 μM staurosporin (Sigma-Aldrich) for 5 h. For a caspase-12 control, HeLa cells were treated with 20 μM A23187 (Calbiochem) for 24 h. Primary and secondary antibodies were diluted as follows: anticaspase-3 polyclonal rabbit antibody (Cell Signaling) at 1:1,000; anticaspase-6 polyclonal antibody (Cell Signaling) at 1:500; anticaspase-7 polyclonal antibody (Cell Signaling) at 1:500; anticaspase-12 polyclonal antibody (14F7; Sigma-Aldrich) at 1:1,000; HRP-conjugated anti-rabbit IgG (GE Healthcare) at 1:3,000; and HRPconjugated anti-rat IgG (Sigma-Aldrich) at 1:20,000.
Cytochrome c release 10 7 primary cortical neurons were treated with 10 μg/ml AMA as indicated (Fig. 3 C) . As a positive control, the same amount of primary cortical neurons were treated with 1 μM staurosporin (Sigma-Aldrich) for 8 h. The cells were washed twice with ice-cold PBS on the dish, collected, and suspended in 500 μl of ice-cold buffer (20 mM Hepes, pH 7.4, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM DTT, 1 mM PMSF, and 250 mM sucrose) and disrupted by moderate strokes in a homogenizer. The homogenate was centrifuged twice at 1,300 g for 5 min to remove nuclei, unbroken cells, and large membrane fragments. From the supernatant, mitochondria were isolated by further centrifugation at 17,000 g and 4°C for 15 min. Pellets were dissolved in the sample buffer described above, separated by 15% SDS-PAGE, blotted to polyvinylidene difl uoride membranes (Fine Trap; Nihon Eido), incubated with cytochrome c monoclonal antibody (1:1,000; Santa Cruz Biotechnology, Inc.), and subjected to HRP-coupled detection. The supernatant of the fi nal centrifugation was used as a cytosolic fraction.
RNA probes for microarray analyses
Cells in culture dishes are harvested in TRIzol reagent (Invitrogen) after rinsing with PBS twice, and total RNA was prepared according to the manufacturer's protocol. Labeling and amplifi cation of RNA was performed using the Agilent Fluorescent Linear Amplifi cation Kit (G2554A; Agilent Technologies) according to the manufacturer's protocol. First, double-stranded cDNAs with a T7 promoter were synthesized from 2 μg of total RNA by Moloney murine leukemia virus reverse transcriptase using an oligonucleotide dT-primer, which contains the T7 promoter sequence, and random hexamers (40°C for 4 h). Then, using these double-stranded cDNAs as templates, cRNA was synthesized by T7 RNA polymerase using Cy3-or Cy5-labeled CTP (40°C for 1 h). cRNAs from AMA-treated cortical neurons, AMA-treated cerebellar neurons, or low potassium-exposed cerebellar neurons were labeled with Cy3 or Cy5. Synthesized cRNA was precipitated with lithium chloride, ethanol rinsed, and dissolved in nuclease-free water. To check the quality of cRNA, OD 260 , OD 280 , A 552 (for Cy3), and A 650 (for Cy5) measurements were taken. Then, OD 260 / OD 280 , amplifi cation rates and dye incorporation rates (pmol/μg RNA) of cRNA were calculated. Using these criteria, we found that our samples were of high quality (OD 260 /OD 280 , <2.0; amplifi cation rate, <400; Cy3 incorporation, <15 [pmol/μg RNA]; and Cy5 incorporation, <12 [pmol/μg RNA]).
Microarray analysis
Hybridization procedures were performed using the In situ Hybridization Kit Plus (5184-3568; Agilent Technologies) according to the manufacturer's protocol. First, Cy3-and Cy5-labeled cRNAs (1 μg each) were mixed and incubated with fragmentation buffer (Agilent Technologies) at 60°C for 30 min. Mouse Development Oligo Microarray (G4120A; Agilent Technologies), which contains 20,371 60-mer oligonucleotides from mouse cDNA, was hybridized with fragmented cRNA targets at 60°C for 17 h using CHBIO (Hitachi). Hybridized microarrays were rinsed twice and dried by spraying N 2 gas (99.999%) using a fi lter-equipped air gun (mycrolis KK; Nihon).
Fluorescent signals were read using a microarray scanner (CRBIO IIe; Hitachi). Data were analyzed using analysis software (DNASIS array; Hitachi). In brief, data either from control spots or from spots containing high intensities of artifi cial signals were removed. Then, the signal intensity of each spot was normalized to equalize total signal intensity. Normalized signal intensity of each spot was plotted on a scatter plot with Cy3 fl uorescence on the y axis and Cy5 fl uorescence on the x axis. The ratio of Cy3/ Cy5 fl uorescence was calculated, and genes with outstanding Cy3/Cy5 ratios of >2.0 or <0.5 were listed.
To confi rm the results, we also used a rat cDNA microarray (G4105A; Agilent Technologies) on which cDNAs (mean length of 500 bases) derived from 14,811 genes were spotted. cDNA probes were labeled by the Direct Label Kit (G2557A; Agilent Technologies) with an oligonucleotide dT primer according to the manufacturer's protocol. The chips were hybridized at 65°C for 17 h and washed with 0.5× SSC and 0.01% SDS for 5 min at RT and with 0.06× SSC for 2 min at RT.
PCR cloning
RT-PCR cloning of YAP was conducted with cDNA reverse transcribed from 1 mg of total RNA prepared from rat cortical neurons by using the RNA LA PCR Kit (Takara) and primers F (5′-G G A A T T C T A T G G A G C C C G C G C A A -3′) and R (5′-A C G C G T C G A C C T A T A A C C A C G T G A G -3′). PCR amplifi cation was performed for 35 cycles (94°C for 30 s, 52°C for 30 s, and 72°C for 90 s). The resultant cDNAs were subcloned between EcoRI and SalI sites of pBluescriptII SK+. Nucleotide sequences were determined by using M13 or synthesized internal primers and the ABI PRISM BigDye Terminator Cycle Sequencing Kit version 3.1 (Applied Biosystems) and ABI PRISM 310 DNA Sequencer (Applied Biosystems). pBluescript plasmids containing 13-, 25-and 61-nt insert forms of YAP were named pBSins13, pBSins25, and pBSins61, respectively. The cDNA of each YAP insert was subcloned into pCI neo (Promega) and denoted pCIins13, pCIins25, and pCIins61, respectively.
Luciferase assay 5 × 10 6 cells MCF-7 cells were transiently transfected with 5 μg of pGL3-Bax-Luc (Strano et al., 2002) with pCI-FL-YAP, -YAP∆C (pCIins13, pCIins25, and pCIins61), or control pCI-neo using LipofectAMINE 2000 (Invitrogen) according to the protocol described previously (Basu et al., 2003) .
Western blot analysis
Cells were resuspended in 62.5 mM Tris-HCl, pH 6.8, 2% (wt/vol) SDS, 2.5% (vol/vol) 2-mercaptoethanol, 5% (vol/vol) glycerin, and 0.0025% (wt/vol) bromophenol blue on culture dishes. Cell lysates prepared from wells containing either 3.3 × 10 4 HeLa cells or 1.0 × 10 5 primary neurons were subject to SDS-PAGE gels, transferred onto polyvinylidene difl uoride membranes (Fine Trap; Nihon Eido), incubated with each primary antibody for 1 h and the corresponding HRP-conjugated secondary antibody for 30 min, and visualized using the ECL Western Blotting Detection System (GE Healthcare). The dilution conditions for primary and secondary antibodies were as follows: anti-YAP polyclonal rabbit antibody (H-125; Santa Cruz Biotechnology, Inc.) at 1:1,000; anti-GAPDH mouse monoclonal antibody (Chemicon) at 1:100,000; HRP-conjugated anti-mouse IgG (GE Healthcare) at 1:5,000; and HRP-conjugated anti-rabbit IgG (GE Healthcare) at 1:3,000. Anti-YAP∆C rabbit polyclonal antibody was raised against the common COOH-terminal peptide (S V F S R D D S G I E D N D N Q ) by immunizing rabbits and was used for Western blotting at a 1:1,000 dilution.
Adenovirus vector construction
The replication-defective adenovirus vectors were constructed by using the Adenovirus Expression Vector Kit (Takara) according to the manufacturer's instructions. In brief, cDNAs of YAP isoforms were digested with EcoRI and SalI from pBSYAP-FL (containing rat FL-YAP), pBSins13, pBSins25, and pBSins61. Ends were blunted using the blunting high kit (Toyobo), and each insert was subcloned into the SwaI site of the pAxCAwt cosmid (Takara). The resultant cosmids were transfected into 293T cells by the calcium-phosphate method with digested DNA of adenovirus and the medium containing dead cells recovered as the virus solution. After two or three rounds of amplifi cation (5 × 10 8 and ‫5ف‬ × 10 9 plaque-forming units/ml), clonality was checked by restriction with endonucleases and PCR. We designated the adenovirus vectors AxCAYAP-FL, AxCAins13, AxCAins25, and AxCAins61. The vectors were used for infection of HeLa cells and primary neurons at a multiplicity of infection (MOI) of 100. Preliminary examination of the effi ciency of protein expression and toxicity of adenovirus was performed by infecting primary neurons with a vector for EGFP and a mock vector at multiple MOI, respectively. More than 90% of the neurons expressed EGFP at an MOI of 100. The difference in cell death percentage between noninfected and mock-infected neurons estimated by trypan blue staining was <3% when the MOI did not exceed 500.
Northern blotting 10 μg of total RNA from primary culture neurons was subjected to electrophoresis using a MOPS/formaldehyde gel. Separated RNAs were
